MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
15.65%
Quick Ratio
12.62%
Debt to Asset Ratio
16.32%
Unit: Thousand (K) dollars
Assets Breakdown
    • Other intangible assets, net
    • Current portion of notes receiva...
    • Inventory
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-controlling interest in subs...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
-
20
3
12
Accounts receivable
0
0
5
15
Cash
10
-
-
-
Inventory
62
63
63
485
Current portion of notes receivable
197
199
198
199
Prepaid expenses and other current assets
51
95
142
206
Total current assets
320
377
411
917
Property, plant and equipment, net
-
-
-
13
Other intangible assets, net
16,425
16,709
16,994
17,278
Total assets
16,745
17,086
17,405
18,208
Accounts payable
467
374
347
576
Accrued expenses
248
210
194
336
Note payable, related party
-
-
-
22,881
Due to related party
1,330
1,103
621
-
Total current liabilities
2,045
1,687
1,162
23,793
Deferred tax liability, net
688
688
688
3,268
Total liabilities
2,733
2,375
1,850
27,061
Preferred stock, 0.001 par value 100,000,000 shares authorized, 60,496,041 shares issued and outstanding (60,496,041 on december 31, 2024) liquidation value 0.001 per share, 60,496,041 aggregate. 60,496,041 on december 31, 2024)
-
-
-
60
Common stock, 0.001 par value 4,000,000,000 shares authorized, 107,821,231 shares issued and outstanding (104,621,231 on december 31, 2025)
108
108
105
12
Additional paid-in capital
63,150
63,150
62,011
42,871
Accumulated deficit
-52,492
-51,794
-49,507
-54,752
Total stockholders equity of the company
10,766
11,464
12,609
-11,809
Non-controlling interest in subsidiaries
3,246
3,247
2,946
2,956
Total stockholders equity
14,012
14,711
15,555
-8,853
Total liabilities and stockholders equity
16,745
17,086
17,405
18,208
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Current portion of notesreceivable$197K (-1.50%↓ Y/Y)Inventory$62K (-87.24%↓ Y/Y)Prepaid expenses andother current assets$51K (-70.18%↓ Y/Y)Cash$10K Other intangibleassets, net$16,425K (-6.49%↓ Y/Y)Total current assets$320K (-78.39%↓ Y/Y)Total assets$16,745K (-12.15%↓ Y/Y)Total liabilities andstockholders equity$16,745K (-12.15%↓ Y/Y)Total stockholdersequity$14,012K (289.86%↑ Y/Y)Total liabilities$2,733K (-89.66%↓ Y/Y)Total stockholdersequity of the company$10,766K (204.11%↑ Y/Y)Non-controlling interest insubsidiaries$3,246K (9.63%↑ Y/Y)Total currentliabilities$2,045K (-91.17%↓ Y/Y)Deferred tax liability,net$688K (-78.95%↓ Y/Y)Accumulated deficit-$52,492K (1.48%↑ Y/Y)Additional paid-in capital$63,150K (47.31%↑ Y/Y)Due to related party$1,330K Accounts payable$467K (-15.70%↓ Y/Y)Accrued expenses$248K (-6.77%↓ Y/Y)Common stock, 0.001 parvalue 4,000,000,000...$108K (800.00%↑ Y/Y)

IMPACT BIOMEDICAL INC. (IBO)

IMPACT BIOMEDICAL INC. (IBO)